The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early.The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early.